<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04034393364247</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Augen OP Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66211225-04</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-05T16:05:10.365Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393344683</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Augen-OP-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66222169-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-05T15:55:56.782Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393343181</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66222209</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-05T15:32:57.362Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393284354</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66218009-06</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:49:12.882Z</lastUpdated>
  </row>
  <row>
    <udiDi>03800238373559</udiDi>
    <basicUdiDi>380023TD03OPHIMV</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>Ophthalmology, Sterile</deviceName>
    <manufacturerName>STS Medical Group AD</manufacturerName>
    <manufacturerSrn>BG-PR-000041814</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S78300129-01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-08-05T12:42:00.385Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393767321</udiDi>
    <basicUdiDi>4034393CPTOPH2B2T</basicUdiDi>
    <tradeName>Augen-OP-Set</tradeName>
    <deviceName>Vitrektomiset Uppsala</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66213366-11</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:24:59.801Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393100937</udiDi>
    <basicUdiDi>4034393CPTOPH1U6</basicUdiDi>
    <tradeName>Katarakt-Set</tradeName>
    <deviceName>IVOM-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>564466</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:23:55.731Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905806</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905806</tradeName>
    <deviceName>Ophthalmology irrigation/aspiration tubing lines</deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>01-Geu-Ext</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T15:26:13.832Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393812199</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66231699-02</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-29T19:54:29.008Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393812113</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66233050-02</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T22:07:41.689Z</lastUpdated>
  </row>
  <row>
    <udiDi>04034393812076</udiDi>
    <basicUdiDi>4034393CPTOPH2A2R</basicUdiDi>
    <tradeName>Katarakt-OP-Set</tradeName>
    <deviceName>Katarakt-Set</deviceName>
    <manufacturerName>Sengewald Klinikprodukte GmbH</manufacturerName>
    <manufacturerSrn>DE-PR-000020748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>66220591-08</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-24T19:56:12.393Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905820</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905820</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-002</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.652Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905943</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905943</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-019</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.502Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905950</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905950</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.472Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905967</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905967</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-004</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.447Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905974</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905974</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-009</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.430Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905981</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905981</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-022</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.397Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512905998</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512905998</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-017</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:33.374Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512906643</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512906643</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1188</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:16.162Z</lastUpdated>
  </row>
  <row>
    <udiDi>03700512915966</udiDi>
    <basicUdiDi>037005129OPH-PEXJ</basicUdiDi>
    <tradeName>03700512915966</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Promepla SAM</manufacturerName>
    <manufacturerSrn>MC-MF-000015769</manufacturerSrn>
    <authorisedRepresentativeName>Promepla Group S.à r.l.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>LU-AR-000013458</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q020601</emdnCode>
    <emdnDescription>PHACOEMULSIFICATION SETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>W-13-004</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-21T17:58:15.293Z</lastUpdated>
  </row>
</eudamedExport>